Summary:
WSA has appointed Dorothea Wenzel to its board of directors and named her chair of the Audit Committee, as Julian Tøpholm steps down.

Key Takeaways:

  • Dorothea Wenzel brings extensive financial and strategic leadership experience from the healthcare and biopharma sectors.
  • She has held high-level board positions at several major organizations, including Fresenius Medical Care and Lundbeck.
  • In her new role, Wenzel will lead WSA’s Audit Committee, focusing on internal audit oversight and risk management evaluation.

WSA announced that Dorothea Wenzel has joined its board of directors and has been appointed chair of the Audit Committee. At the same time, Julian Tøpholm is stepping down from the Board.

Wenzel joins as an independent director with an impressive track record in finance and strategy leadership across multiple industries, including a long career at the biopharmaceutical company Merck KGaA, where she held several commercial and financial executive positions. She has extensive experience in leading business transformations, and significant board experience from Dentsply Sirona Inc., Servier Group, Gerresheimer, and as lead independent director at Fresenius Medical Care AG & Co. Most recently, she was appointed chair of Lundbeck, following her tenure as chair of its Audit Committee.

“We are delighted to welcome Dorothea to the WSA Board,” says WSA Chair Lars Rasmussen. “Her broad business and finance background, as well as her considerable experience as a director, will ensure that the work of the Audit Committee strongly supports WSA’s strategic priorities and reporting responsibilities. I look forward to collaborating with Dorothea, and I would like to thank Julian Tøpholm for his valuable contributions to WSA’s development.”

In her new role, Wenzel will oversee the Audit Committee’s responsibilities, including oversight of internal audit functions, and evaluation of risk management processes.

The WSA Board of Directors consists of:

•              Lars Rasmussen (Chair)

•              Adam Westermann (Vice Chair)

•              Arne Due-Hansen

•              Jes Munk Hansen

•              Kristiaan Nieuwenburg

•              Karen Prange

•              Anthony Santospirito

•              Dorothea Wenzel

About WSA

WSA is a global pure-play hearing healthcare group that operates in over 130 markets and employs more than 12,500 people across our innovative brand platforms, Widex and Signia, and a global network of hearing care professionals and consumer-facing businesses. WSA is privately owned by the Tøpholm and Westermann families, the Lundbeck Foundation, EQT and ATHOS KG. Learn more at www.wsa.com.